Conghui Han

6.2k total citations · 4 hit papers
76 papers, 4.6k citations indexed

About

Conghui Han is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Conghui Han has authored 76 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 17 papers in Surgery and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Conghui Han's work include Bladder and Urothelial Cancer Treatments (12 papers), Cancer Research and Treatments (9 papers) and Epigenetics and DNA Methylation (7 papers). Conghui Han is often cited by papers focused on Bladder and Urothelial Cancer Treatments (12 papers), Cancer Research and Treatments (9 papers) and Epigenetics and DNA Methylation (7 papers). Conghui Han collaborates with scholars based in China, United States and Bangladesh. Conghui Han's co-authors include Zhenduo Shi, Hao Lin, Zhiguo Zhang, Gang Wang, Yang Dong, Kun Pang, Zhe‐Sheng Chen, Lin Hao, Zhuo‐Xun Wu and Jiaxin Qin and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The FASEB Journal.

In The Last Decade

Conghui Han

71 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis

2013 3.5k citations Hao Lin, Zhenduo Shi et al. profile →
Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade

2022 152 citations Kun Pang, Zhenduo Shi et al. Drug Resistance Updates profile →
Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms

2023 125 citations Conghui Han et al. Drug Resistance Updates profile →
Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies

2023 125 citations Zhenduo Shi, Kun Pang et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Conghui Han China	17	1.1k	881	757	676	422	76	4.6k
Zhenduo Shi China	16	991 0.9×	831 0.9×	624 0.8×	640 0.9×	403 1.0×	63	4.5k
Zhiguo Zhang China	23	968 0.9×	741 0.8×	789 1.0×	448 0.7×	394 0.9×	103	5.2k
Chen‐Li Cheng Taiwan	30	962 0.9×	893 1.0×	1.1k 1.5×	414 0.6×	608 1.4×	204	5.3k
Chung‐Han Ho Taiwan	28	664 0.6×	518 0.6×	528 0.7×	393 0.6×	719 1.7×	295	3.7k
Sadao Suzuki Japan	42	813 0.8×	619 0.7×	778 1.0×	927 1.4×	819 1.9×	222	5.3k
Yolanda B. de Rijke Netherlands	51	814 0.8×	897 1.0×	1.2k 1.6×	534 0.8×	1.0k 2.4×	245	8.9k
Hyun Jung Kim South Korea	39	2.3k 2.1×	861 1.0×	357 0.5×	434 0.6×	727 1.7×	256	5.5k
Tun‐Jun Tsai Taiwan	41	928 0.9×	758 0.9×	938 1.2×	249 0.4×	588 1.4×	177	5.3k
Fulvio Zullo Italy	56	1.2k 1.1×	586 0.7×	1.2k 1.6×	622 0.9×	810 1.9×	380	11.8k
Adelin Albert Belgium	46	1.6k 1.5×	959 1.1×	854 1.1×	635 0.9×	824 2.0×	291	7.6k

Countries citing papers authored by Conghui Han

Since Specialization

Citations

This map shows the geographic impact of Conghui Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conghui Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conghui Han more than expected).

Fields of papers citing papers by Conghui Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Conghui Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conghui Han. The network helps show where Conghui Han may publish in the future.

Co-authorship network of co-authors of Conghui Han

This figure shows the co-authorship network connecting the top 25 collaborators of Conghui Han. A scholar is included among the top collaborators of Conghui Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Conghui Han. Conghui Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Wei, et al.. (2024). Research Advances in Stem Cell Therapy for Erectile Dysfunction. BioDrugs. 38(3). 353–367. 8 indexed citations

Sun, Qian, Yanyu Li, Yang Wen, et al.. (2024). CircMYH9/miR-133a-3p/CXCR4 axis: a novel regulatory network in sperm fertilization and embryo development. Molecular Biomedicine. 5(1). 69–69.

Shi, Zhenduo, Zhuo Sun, Zuobin Zhu, et al.. (2023). Integrated single‐cell and spatial transcriptomic profiling reveals higher intratumour heterogeneity and epithelial–fibroblast interactions in recurrent bladder cancer. Clinical and Translational Medicine. 13(7). e1338–e1338. 23 indexed citations

Zhang, Zhiguo, Zhenduo Shi, Jiajun Dong, et al.. (2023). Novel potential urinary biomarkers for effective diagnosis and prognostic evaluation of high-grade bladder cancer. Translational Cancer Research. 12(8). 1992–2007. 3 indexed citations

Shi, Zhenduo, Kun Pang, Zhuo‐Xun Wu, et al.. (2023). Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies. Signal Transduction and Targeted Therapy. 8(1). 113–113. 125 indexed citations breakdown →

Shi, Zhenduo, Zijian Song, Kun Pang, et al.. (2023). Integrative multi-omics analysis depicts the methylome and hydroxymethylome in recurrent bladder cancers and identifies biomarkers for predicting PD-L1 expression. Biomarker Research. 11(1). 47–47. 5 indexed citations

Lu, Hao, et al.. (2023). Lutetium Lu 177 vipivotide tetraxetan for prostate cancer. Drugs of today. 59(1). 37–49. 4 indexed citations

Han, Conghui, et al.. (2022). An azoospermic male with a novel chromosome 46, XX , der(15)t(Y; 15)(p11.3; p12). SHILAP Revista de lepidopterología. 10(7). e5984–e5984. 1 indexed citations

Pang, Kun, Wei Wang, Jiaxin Qin, et al.. (2022). Role of protein phosphorylation in cell signaling, disease, and the intervention therapy. SHILAP Revista de lepidopterología. 3(4). e175–e175. 74 indexed citations

10.

Shi, Zhenduo, Lin Hao, Xiaoxiao Han, et al.. (2022). Targeting HNRNPU to overcome cisplatin resistance in bladder cancer. Molecular Cancer. 21(1). 37–37. 77 indexed citations

11.

Pang, Kun, Zhenduo Shi, Liuya Wei, et al.. (2022). Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade. Drug Resistance Updates. 66. 100907–100907. 152 indexed citations breakdown →

12.

Pang, Kun, Yang Dong, Lin Hao, et al.. (2022). ERH Interacts With EIF2α and Regulates the EIF2α/ATF4/CHOP Pathway in Bladder Cancer Cells. Frontiers in Oncology. 12. 871687–871687. 9 indexed citations

13.

Wu, Xiaodong, et al.. (2021). ROS-Sensitive Nanoparticles Co-delivering Dexamethasone and CDMP-1 for the Treatment of Osteoarthritis Through Chondrogenic Differentiation Induction and Inflammation Inhibition. Frontiers in Bioengineering and Biotechnology. 9. 608150–608150. 26 indexed citations

14.

Zhang, Shaoqi, Zhenduo Shi, Kun Pang, et al.. (2020). MAP30 Inhibits Bladder Cancer Cell Migration and Invasion In Vitro Through Suppressing Akt Pathway and the Epithelial/Mesenchymal Transition Process. DNA and Cell Biology. 39(11). 1948–1960. 9 indexed citations

15.

Pang, Kun, Jianjun Zhang, Bo Chen, et al.. (2019). Guiding role of seminal tract anatomical study in transurethral seminal vesiculoscopy.. Videosurgery and Other Miniinvasive Techniques. 15(1). 176–184. 3 indexed citations

16.

Wang, Yiqiu, Ying Ding, Chao Qin, et al.. (2018). Expression of vitamin D receptor in clear cell papillary renal cell carcinoma. Annals of Diagnostic Pathology. 36. 1–4. 1 indexed citations

17.

Zhang, Zhiguo, et al.. (2015). Optimization Studies on Prokaryotic Cell Expression of the Human Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL). Cell Biochemistry and Biophysics. 73(2). 275–279. 1 indexed citations

18.

Cao, Yong, Lin Hao, Conghui Han, & Pei-Ying Zhang. (2014). Protective Effects of Wusen Erlian Granules in Experimental Model of Viral Myocarditis. Cell Biochemistry and Biophysics. 71(2). 1129–1133. 2 indexed citations

19.

Gong, Zhen, Conghui Han, & Lin Hao. (2009). Preparation and stimulatory bioactivity evaluation of conjugate of superantigen and the Fab frag ment of McAb against human bladder carcinoma. Zhonghua shiyan waike zazhi. 26(1). 89–91. 1 indexed citations

20.

Gong, Zhen, et al.. (2009). Preparation and in-vitro bioactivity of a novel superantigen conjugate targeting bladder carcinoma. Journal of Pharmacy and Pharmacology. 61(7). 869–875. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact